Valneva SE
VALN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001836564
No open-market purchases or sales by Valneva SE insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $19.8M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −1 vs. previous quarter
- 20
- 13F valueReported value at the end of Q2 2026
- $19.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding VALN, Q2 2026
No superinvestor reported holding VALN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Valneva SE insiders from Form 4, newest first.
No open-market purchases or sales by Valneva SE insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Valneva SE at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 2,291,666 | $12.0M | 0.26% | 00.0% | Unchanged |
| Vivo Capital, LLC | 763,199 | $3.99M | 0.36% | +763,199 | New |
| General American Investors Co Inc | 354,361 | $1.85M | 0.11% | 00.0% | Unchanged |
| Millennium Management LLC | 135,223 | $707.2K | 0.00% | +135,223 | New |
| Wells Fargo & Company | 77,214 | $403.8K | 0.00% | −815−1.0% | Reduced |
| Morgan Stanley | 56,217 | $294.0K | 0.00% | +9,292+19.8% | Added |
| Ironwood Investment Management LLC | 45,064 | $235.7K | 0.08% | +19,929+79.3% | Added |
| Citadel Advisors LLC | 20,294 | $106.1K | 0.00% | +20,294 | New |
| XTX Topco Ltd | 15,178 | $79.4K | 0.00% | +15,178 | New |
| VSM Wealth Advisory, LLC | 10,000 | $52.3K | 0.01% | 00.0% | Unchanged |